3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID, 95.0%, 100mg

1-methylpyrazole-3-sulfonamide, 97%, 1g

4-(2,6-di-tert-butyl-4-((2-((3,5-di-tert-butyl-4-hydroxyphenyl)thio)propan-2-yl)thio)phenoxy)-4-oxobutanoic acid, 98%, 5mg

L-Homocitrulline, 95.0%, 5g

N-[(1,1-Dimethylethoxy)carbonyl]-D-homocysteine, 98%, 1g

Ethyl 3-tert-butyl-1-methyl-1H-pyrazole-5-carboxylate, 95.0%, 10g

Ethyl tetrahydro-2H-pyran-4-carboxylate, 97.0%, 25g

Ethylene Glycol Mono-m-tolyl Ether>98.0%(GC)5mL

TRANS-3-FLUORO-4-METHYLPIPERIDINE HCL, 95.0%, 500mg

Boc-His(Boc)-OH DCHA salt, 99%, 10g

6-Bromo-N,N-dimethylpyridin-3-amine, 95.0%, 250mg

5-Bromo-6-methyl-1H-indole, 95.0%, 10g

Acido 5-fluoroorotico, min 98%, per biochimica, 2,5 g, confezione in vetro